8Om Anand,Lawrence X Yu,Dale P. Conner,et al. Davit. Dissolu- tion testing for generic drugs: An FDA perspective [ J ]. AAPS J, 2011,13(3) :328 -335.
9Jordan K M, Arden N K, Doherty M, et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) [ J ]. Annals of the rheumatic diseases, 2003, 62 (12) : 1145-1155.
10Zhang W, Moskowitz R W, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II : OARSI evidence- based, expert consensus guidelines [ J ]. Osteoarthritis and cartilage, 2008, 16(2): 137-162.
